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Abstract
Background: National guidelines recommend that patients with rheumatic diseases should have access to podiatry services and evidence
is emerging that podiatry interventions are effective in the management of foot problems in this patient group. Despite this recognition
it is generally perceived that access to podiatry services appears to be varied or absent. Objectives: To identify the nature of foot health
problems presenting in a rheumatology clinic and to ascertain the availability and suitability of foot care for these problems. Method: A
convenience sample of 139 patients (100 female and 39 male) was recruited. An assessment of foot health, and footwear was carried out
and patients completed the foot function index (FFI). Any unmet foot care needs were identified. Results: The majority of the 139 patients
presented with symptomatic callus and toenail problems and over half with foot deformity. There was no clear difference between genders.
There was evidence of the effects of foot pain caused by these problems but low prescription of foot orthoses and specialist footwear.
Conclusion: Overall this study indicates that poor foot health and foot pain as being common in patients with rheumatic diseases. The
lack of foot care could lead to reduction in mobility and in some cases serious complications. This paper recommends that a specialist and
dedicated foot care service is provided for these patients.
© 2004 Elsevier Ltd. All rights reserved.
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1. Background
We are now in the Bone and Joint Decade [1] and the
challenge has been firmly placed for all health care profes-
sionals to improve the services for patients with rheumatic
diseases so that they can receive care in an appropriate and
timely way. The ultimate aim of this challenge is to reduce
the impact of rheumatic disease by reducing pain, improv-
ing mobility and thereby limiting the effects of disability.
The evidence base for dedicated podiatry as part of mul-
tidisciplinary foot clinics in diabetes is well established [2]
but this has yet to be achieved for rheumatology services.
However, the role of the podiatrist in the rheumatology team
is becoming recognised as a vital component in the inte-
grated care given to patients by the multidisciplinary team
[3,4]. Increasingly consultants and their teams are request-
ing specialist foot care services and it is suggested that the
podiatrist is a key practitioner in the management of pa-
tients with musculoskeletal disease [4–6]. It has been rec-
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ommended [7–9] that patients should understand the role
and have access to a podiatrist. Despite this recognition it is
generally perceived that access to podiatry services for pa-
tients with rheumatic diseases appears to be varied and in
some instances absent.
Foot involvement has been reported in between 50 and
89% of patients with rheumatoid arthritis (RA) [10,11] with
the basic pathological changes involving a combination of
synovitis and mechanical stress [12]. Common manifesta-
tions include hallux valgus, valgus heel deformity and lesser
toe deformities, which cause severe foot pain and reduced
mobility. This foot deformity also predisposes to callus for-
mation and in a number of patients, foot ulceration, partic-
ularly in cases with poor tissue viability. Bacterial, fungal
skin and nail infections are more prevalent in this patient
group adding to the serious risk of ulceration (Fig. 1) and
systemic infection. This risk of infection is further increased
if the patient’s medical management is by immunosuppres-
sive drugs [13,14].
It is reported [15] that the goals of foot care for patients
with RA are to relieve pain, maintain function and improve
the quality of life using safe and cost-effective treatments,
such as palliative foot care, prescribed foot orthoses and
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Fig. 1. Ulcerated feet associated with RA foot deformity.
specialist footwear. Small trials and case reports have pro-
moted the value of prescribed orthoses and footwear in the
management of the rheumatoid foot [16–18]. It is known
that early intervention with foot orthoses reduces foot pain
and has a sustained effect in reducing the impact of abnor-
mal foot function and disability [19]. The value of podiatry
involvement in the assessment of patients for prescription
footwear has been highlighted and has been shown to im-
prove compliance with this intervention [20].
Foot problems are known to occur in other rheumatic dis-
eases. In patients with systemic sclerosis, painful and poten-
tially limb threatening foot problems occur in the majority
of cases [21]. It is recognised that the care of the feet is
important in preventing major foot problems and amputa-
tions in this patient group. The role of the podiatrist in the
orthotic management of juvenile chronic arthritis has been
highlighted as being essential [22] and a significant reduc-
tion of reported pain in osteoarthritic knees has been demon-
strated when patients were provided with foot orthoses [23].
Specific tools for measuring the impact of foot pathol-
ogy on foot pain function and disability in patients with
rheumatic diseases have been used in research [24,25] and
are now available for use in clinical practice.
The aim of this study was to identify the nature of foot
problems experienced by patients attending the rheumatol-
ogy outpatient’s clinic at Rochdale Infirmary and to ascer-
tain the availability of foot care services for these patients.
At the start of the study it was known that at Rochdale Infir-
mary there was no dedicated specialist podiatry service for
patients attending the Rheumatology Department. However,
a small number of referrals were being sent to the podi-
atrists working alongside the orthopaedic consultants. The
community podiatry service provided a foot care service to
which patients could refer themselves.
2. Patients and methods
A convenience sample of 139 patients (100 female and 39
male) was recruited whilst attending the Rheumatology out-
patient department at Rochdale Infirmary. The outpatients
nurses asked each patient attending the clinic if they agreed
to their foot health being assessed even if they were already
attending a podiatry service. Patients underwent an assess-
ment as part of their consultation with the rheumatologist.
Time was a limiting factor, therefore, only an average of
eight patients were assessed in each clinic. No patient who
was asked refused assessment.
The assessment included a foot health and footwear as-
sessment carried out by an experienced podiatrist. In an at-
tempt to increase objectivity and reduce bias, the podiatrist
was not employed by the trust and was wholly independent
from the service.
2.1. Foot health assessment
All patients had both feet examined. The presence of foot
deformity, sites of callus formation, presence or history of
ulceration, fungal infections of the skin and nails and other
abnormalities were recorded on an assessment sheet. Foot
pulses were assessed as being absent or weak or strong.
colour changes and thinning of the skin were also noted.
The patients were then categorised as having poor or good
tissue viability. An objective assessment of footwear was
carried out by the podiatrist, to ascertain the type and appro-
priateness of the patients footwear for the patients particular
foot problems. This assessment was based on the specific
variables of the shoe construction such as heel height, fas-
tenings, sole thickness, heel counter thickness and overall
shape of the shoe [26,27].
The patients were asked if they had any problems with the
footwear, if they thought the footwear was suitable for their
needs and if the footwear was comfortable. Similarly those
patients who had been provided with foot orthoses were
asked about the suitability of the devices and if they had
been beneficial in reducing foot pain and providing stability.
A biomechanical assessment was carried out on all patients.
Patients were also questioned about if they received pro-
fessional foot care and what interventions were used (such
as palliative care, foot orthoses or specialist footwear). Fi-
nally, the assessing podiatrist identified the patient’s current
and long term foot care needs.
2.2. Foot function index
The patients completed the foot function index (FFI) ques-
tionnaire following verbal instruction by the podiatrist. The
foot function index [24], is a validated self-administered
questionnaire that provides an index of foot pain, subse-
quent activity limitation and disability. The FFI consists of
23 items grouped in three domains: foot pain (9 items),
disability (9 items) and functional limitation (5 items). All
items are rated using a visual analogue scale and the higher
scores indicate greater pain, disability and limitation of ac-
tivity, and thus poorer foot health. To obtain a domain score,
the item scores are totalled and divided by the total possible
score of the number of items the patient indicated as appli-
cable. This score for each domain is then multiplied by 100
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and the total FFI score is the average of the three domain
scores.
3. Results
The patients presented with a variety of rheumatic dis-
eases, the majority presenting with rheumatoid arthritis and
osteoarthritis (Table 1). With regards to co-morbid or asso-
ciated conditions, which may present with manifestations in
the lower limb, two patients presented with type 2 diabetes,
three with Raynauds syndrome and three with vasculitis.
Overall, there was no difference between gender in the
presenting foot problems and footwear suitability.
Over half (58%) the patients in the study presented with
symptomatic callus under the foot (n = 81) and/or on the
toes (Fig. 2). There was a high prevalence of nail pathologies
ranging from fungal infections of the nail (11%, n = 15) to
thick and deformed nails (68%, n = 86) and ingrown toes
nails (4%, n = 6). Twenty-seven patients (19%) presented
with plantar bursae and 6 (8%) with nodules. Only 17 (12%)
had no cutaneous, nail or soft tissue problems.
Only 51% (n = 69) of the total 139 patients were as-
sessed by the podiatrist as having suitable retail footwear.














Mixed connective tissue disorder (CTD) 1
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Undifferentiated CTD 1
Fig. 2. Pressure lesions on the toes of a patient with RA.
Table 2
Patients foot care requirements
Immediate 20% (n = 28)
Routine foot care 72% (n = 100)
Footwear advice 61% (n = 85)
Foot orthoses 60% (n = 83)
Prescription footwear 10% (n = 14)
No foot care required 8% (n = 11)
problem (n = 122) 62 had inadequate footwear contribut-
ing to or exacerbating their foot problems. Therefore, seven
patients with unsuitable footwear avoided foot problems.
Twenty (14%) of the 139 patients had been prescribed spe-
cialist footwear. However, a combination of the podiatrist’s
assessment and the patients opinion described 10 (50%) of
these being inadequate due to poor fit, excessive wear and/or
lack of comfort.
Over half of the patients were assessed as having poor
tissue viability plus moderate to severe foot deformity (such
as hallux abducto-valgus, clawing of the lesser toes, exces-
sive pronation, and/or subluxation of joints) placing them at
risk from foot ulceration.
Eleven (8%) patients had been supplied with foot orthoses.
However, eight were deemed inadequate in reducing foot
pain by the patient and four of these could not be used
because they were either too hard or would not fit into the
patients shoes. Following biomechanical assessment of all
patients 83 (60%) were assessed as requiring foot orthoses
as an intervention (Table 2).
Two patients had previously undergone foot surgery.
One patient had a Fowler’s procedure carried out by an
orthopaedic surgeon and one patient had a second toe
straightened by a podiatric surgeon. One further patient
would have benefited from foot surgery for gross hallux
abducto-valgus and hammer toes. A referral to the podiatric
surgeon was carried out.
All patients completed the foot function index in full. The
Foot Function Index demonstrated the effects of foot pain
caused by joint and foot problems as demonstrated in the
total FFI scores with a median score 45 (range = 32–80).
All patients reported some level of foot pain. Ten patients
reported extreme pain and this was reflected in their FFI
scores. These patients were recently diagnosed with rheuma-
toid arthritis or were experiencing a flare of the disease.
With regards to professional foot care, over half (60%,
n = 83) the patients had never received foot care, 21%
(n = 30) received NHS foot care at their local clinic and
19% (n = 26) had to purchase foot care privately. The use
of private foot care was due to due to inaccessibility or
infrequency of foot care at their local NHS clinic or as in
two cases, personal choice. No patient in this study received
foot care by a podiatrist specialising in the management of
patients with rheumatic diseases.
The patient’s foot care requirements as assessed by an
experienced podiatrist are summarised in Table 2.
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4. Conclusions
Overall this study demonstrates that in this particular out-
patient clinic, poor foot health and foot pain is highly preva-
lent in patients with rheumatic diseases. The impact of these
problems results in various levels of functional limitation
and disability in patients with both acute and chronic dis-
ease. The prevalence of plantar callosities (58%) and self
reported foot pain (all reported some level of pain) is greater
in this study compared with a study of older adults (31%
presenting with plantar callus and 21% reported pain) [28].
Measurement of plantar foot pressures may have been a
useful addition in the assessment of these patients. However,
time constraints and lack of access to specialist equipment
precluded this element of patient assessment.
When specialist professional foot care is provided, the po-
tential benefits are improved foot health, reduction of foot
pain and an improvement in general well-being. However,
the provision of foot care for the patients in this study was
inconsistent, untimely and sometimes inappropriate. An ex-
ample of this was over debridement of plantar callus. A
small clinical trial suggests that in patients with rheumatoid
arthritis, reduction of plantar callus results in reduced foot
pain but only for a period of 7 days; increased peak plantar
pressures were demonstrated in 10 of the fourteen feet as-
sessed [29]. This increase in plantar peak pressures and the
loss of the protective nature of callus formation over promi-
nent metatarsal heads puts the foot at risk of tissue necrosis
and ulceration. In addition there was evidence of the use of
adhesive padding in patients with low tissue viability. Adhe-
sive padding causes maceration of the skin and a breakdown
in the skins natural protection against opportunistic bacteria
and fungal spores. Therefore, clinical guidelines [30] sug-
gest that this practice is not recommended in patients with
low tissue viability and compromised immune systems.
There was little evidence in this study of appropriate foot
orthoses, although studies support their use in both early and
late RA [16–18]. Likewise, there was little use of specialist
footwear even though the benefits of this intervention have
been documented [18]. In a review of 109 patients who
attended a multidisciplinary rheumatology foot clinic [6]
53 patients reported foot pain, 83 were provided with foot
orthoses and 47 provided with specialist footwear (33 stock
shoes, 14 bespoke).
Patients with autoimmune disorders, and/or taking medi-
cation that compromises the immune system should be con-
sidered at risk of infection and foot ulceration, and therefore,
should receive priority for specialist foot care. Likewise, pa-
tients with micro-vascular and/or large vessel disease, foot
deformity and poor footwear are also at risk of foot trauma,
ulceration and subsequent infection. Timely and appropriate
specialist foot care and interventions are essential if we are to
reduce the impact of foot problems in this patient group. The
North West Clinical Effectiveness Guidelines for the Foot in
Rheumatic Diseases [30] recommend that a specialist podi-
atrist should become a recognised member of the rheuma-
tology multidisciplinary team and become the clinical lead
for foot problems associated with rheumatic diseases.
The results of this study supports the case for a dedicated
and specialist foot care service to patients with rheumatic
diseases in this locality whatever the patients age or stage
of disease. However, the following recommendations could
be applied to any rheumatology service. This paper recom-
mends that in order to identify patients with foot problems,
their consultant or specialist nurse should question patients
about their feet. If foot problems are identified a referral to
the specialist podiatrist should be made. Patients with dis-
abling foot pain or who are at risk of foot ulceration should
receive priority foot care. Foot orthoses should be considered
for patients recently diagnosed with rheumatoid arthritis as
this intervention has been demonstrated to reduce pain and
the effects of abnormal joint function in the foot [19]. Spe-
cialist prescription footwear should be available for patients
who cannot fit into appropriate retail footwear and in this
area podiatrists and orthotists should collaborate to achieve
the optimal clinical outcome [20].
This study demonstrates that there is an unmet need for
specialist professional foot care in patients attending this
particular rheumatology outpatient clinic. This may be the
same for any rheumatology service where podiatrists are not
part of the multidisciplinary rheumatology team and have
not received specialist training in this area. However, larger
multi-centre studies are required to investigate the scale of
foot problems nationally. Rheumatology teams and podia-
try services should collaborate and aim to improve the foot
health service to patients with these disabling foot problems,
if we are to meet the challenge of the Bone and Joint Decade
[1].
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